Pacific Edge Diagnostics USA Ltd.

Pacific Edge Diagnostics USA Ltd. is the U.S. arm of Pacific Edge, a cancer diagnostics company headquartered in New Zealand. The group develops and commercializes Cxbladder, a suite of non-invasive, urine-based genomic biomarker tests designed to support bladder cancer rule-out and surveillance. Pacific Edge reports operating U.S. laboratories certified by CLIA, CAP, and New York State.